Brief: Valbiotis confirms efficacy of Lipidrive in three models and finalizes recruitment for phase I/II
Oct 16 (Reuters) - VALBIOTIS SAS ALVAL.PA :
* LIPIDRIVE: EFFICACY CONFIRMED IN THREE MODELS,
FINALIZATION OF RECRUITMENT FOR PHASE I/II IN HUMANS
* IN PROCESS OF RECRUITING 20 OBESE MALE VOLUNTEERS FOR
STUDY, 18 OF WHICH HAVE ALREADY BEEN INCLUDED
Source text for Eikon: ID:nBw3mL7ra
Further company coverage: ALVAL.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Valbiotis SA
See all newsBrief: Valbiotis Announces Creation By Chinese JV Of Subsidiary In Singapore
French and Benelux stocks-Factors to watch
Brief: Valbiotis FY Operating Profit Eur -9.5 Mln
Brief: Valbiotis Launches Capital Increase For Gross Amount Of Nearly EUR 6.9 Mln
Brief: Valbiotis Signs Strategic Agreements With Two Pharmaceutical Groups